Evening of Impact Gala

e.givesmart.com/events/BfX/



The Alzheimer’s Association Evening of Impact Gala brings together our incredible community of supporters, partners and community leaders in celebration of the strides that we have made in the fight against Alzheimer’s and all other dementia. This annual event allows us to share critical advancements in research, treatment and advocacy and helps us raise the necessary funds to continue moving the mission forward.



Each year, we honor local champions who live by our mission and work tirelessly to create a world without Alzheimer’s. 

To purchase tables/tickets, please click here. 

KARL SCHNEIDER & WHITNEY LUCKS
EVENT CHAIRS, 2024 EVENING OF IMPACT GALA
"It is our pleasure and honor to chair the 2024 Evening of Impact Gala. We invite you to join us in supporting the work of the Alzheimer’s Association of Central Ohio, whose staff is changing lives by providing critical support and resources to local families affected by this terrible disease. The Alzheimer’s Association is also the top nonprofit funder of Alzheimer’s research. 2023 was a banner year for medical advancement, but the work is far from done."

Thank you for standing with us in the fight against Alzheimer’s.

2024 Community Impact Award Recipient

Dr. Douglas Scharre
Director, Division of Cognitive Neurology
Director, The Ohio State University Center for Cognitive and Memory Disorders
Professor of Clinical Neurology and Psychiatry

Dr. Douglas Scharre is a clinical neuroscience researcher and behavioral neurologist specializing in the diagnosis and management of cognitive issues with over 29 years of experience. He has conducted or participated in over 200 clinical research studies funded by NIH, foundations and industry utilizing neuroimaging, serum and cerebrospinal fluid biomarkers, cognitive biomarkers, genetic biomarkers and cognitive, functional, and behavioral scales on mild cognitive impairment, dementia and control subjects.

The data from these OSU research subjects have contributed to over 1,000 research publications. He is a contributing member of several national research and NIH supported consortiums including the Alzheimer’s Disease Cooperative Study (ADCS) group, Alzheimer’s Disease Neuroimaging Initiative (ADNI), Global Alzheimer’s Platform (GAP), and the Alzheimer’s Clinical Trials Consortium (ACTC).

His center is designated as one of the funded Lewy Body Dementia Association Research Center of Excellence (LBDA RCOE). He has designed and developed both paper and digital versions of the Self-Administered Gerocognitive Examination (SAGE), a cognitive assessment instrument designed for identifying in a practical way with mild cognitive impairment or early dementia from any cause and to be sensitive to changes over time.

He was selected by his peers as one of the Best Doctors in America for 17 years in a row. Dr. Scharre joined The Ohio State University Wexner Medical Center faculty in the Department of Neurology in 1993.
                       

To purchase tables/tickets, please click here.